Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Organ Transplant Immunosuppressant Drugs Market Valued at Present and by 2029?

The market size for cancer supportive care drugs has consistently expanded over recent years. It’s forecasted to enhance from $20.83 billion in 2024 to $21.54 billion in 2025, achieving a compound annual growth rate (CAGR) of 3.4%. Several factors contribute to this historical growth, such as the growing aged population, increased frequency of chemotherapy, heightened demand for antiemetics, the shifting preference towards online pharmacies and drug outlets, augmented awareness about supportive care, growing implementation of customised medication, and an increasing focus on palliative care.

In the coming years, a consistent rise is anticipated in the cancer supportive care drugs market. It’s projected to escalate to “$25.07 billion in 2029 with a compound annual growth rate (CAGR) of 3.9%. The reasons enabling this growth throughout the forecast period include increased awareness of the negative impacts of cancer treatments, rising instances of breast cancer among women, the provision of customised medication schemes, increasing demand for online medical consultations and betterment of the pharmaceutical supply chain, as well as the growing population of cancer survivors. Key trends to watch out for in the forecast period includes progress in targeted therapies, incorporation of biobehavioral interventions, deployment of survivorship care strategies, integration of nutritional support, advancements in approaches to pain management, and the application of symptom tracking platforms.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15749&type=smp

#What Drivers Are Influencing Growth In The Organ Transplant Immunosuppressant Drugs Market?

The organ transplant immunosuppressant drugs market is projected to grow due to the rising need for organ transplants. Organ transplants are medical procedures where a failing or diseased organ is replaced by a healthy organ from a donor, saving the recipient’s life. It is essential to have immunosuppressant drugs during such procedures to avoid organ rejection, the success of the transplant heavily relies on the availability and effectiveness of these drugs. Take for example, the Organ Procurement and Transplantation Network (OPTN), a public-private partnership based in the US, reported in 2023 that about 16,335 individuals donated one or more organs posthumously. This is the first time that the number of deceased donors has crossed 15,000, signifying a 9.6% year over year increase from 2022. Hence, the heightened demand for organ transplants is anticipated to fuel the growth of the organ transplant immunosuppressant drugs market.

The cancer supportive care drugs market covered in this report is segmented –

1) By Type: Erythropoiesis Stimulating Agents, Granulocyte Colony Stimulating Factors, Antiemetics, Bisphosphonates, Opioids, Nonsteroidal Anti Inflammatory Drugs, Other Types

2) By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Stomach Cancer, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics, Other Channels

Subsegments:

1) By Erythropoiesis Stimulating Agents: Epoetin Alfa, Darbepoetin Alfa, Methoxy Polyethylene Glycol-Epoetin Beta

2) By Granulocyte Colony Stimulating Factors: Filgrastim, Pegfilgrastim, Lenograstim

3) By Antiemetics: 5-HT3 Receptor Antagonists, NK1 Receptor Antagonists, Corticosteroids

4) By Bisphosphonates: Zoledronic Acid, Pamidronate, Ibandronate

5) By Opioids: Morphine, Fentanyl, Oxycodone

6) By Nonsteroidal Anti Inflammatory Drugs (NSAIDs): Ibuprofen, Diclofenac, Celecoxib

7) By Other Types: Steroids, Anxiolytics, Appetite Stimulants

What Notable Trends Are Shaping The Direction Of The Organ Transplant Immunosuppressant Drugs Market?

Top-tier businesses in the cancer support care drugs market are innovating combination therapies to tackle the intricacies and obstacles in cancer cure. These therapies involve the calculated use of multiple therapeutic agents to address various dimensions of cancer progression and survival, with the goal of achieving more profound and long-lasting results than monotherapy. For example, in November 2023, the US-based pharmaceutical leader, Merck, gained approval from the Food and Drug Administration (FDA), a US federal agency, for KEYTRUDA, an anti-PD-1 therapy, to be used in combination with gemcitabine and cisplatin. This was for treating patients suffering from locally advanced inoperable or metastatic biliary tract cancer (BTC). This combined treatment has demonstrated hopeful outcomes in augmenting overall survival and offering a fresh treatment alternative for patients grappling with this demanding condition.

Which Companies Play A Key Role In The Development Of The Organ Transplant Immunosuppressant Drugs Market?

Major companies operating in the cancer supportive care drugs market are Pfizer Inc., Johnson & Johnson, Merck, AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Novartis AG, F Hoffmann-La Roche Ltd., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Eisai Co. Ltd., Incyte Corporation, Exelixis Inc., Fagron Group, Heron Therapeutics Inc., Athenex Inc., Acrotech Biopharma LLC

https://www.thebusinessresearchcompany.com/report/cancer-supportive-care-drugs-global-market-report

What Are The Key Regional Developments Shaping The Organ Transplant Immunosuppressant Drugs Market?

North America was the largest region in the cancer supportive care drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer supportive care drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15749&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model